A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
about
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of AC Followed by a Co ...... ositive Invasive Breast Cancer
@en
type
label
A Study of AC Followed by a Co ...... ositive Invasive Breast Cancer
@en
prefLabel
A Study of AC Followed by a Co ...... ositive Invasive Breast Cancer
@en
P4844
P6153
P131
P1476
A Randomized Phase III Trial o ...... f Pathologic Complete Response
@en
P3098
NCT00486668
P580
2007-07-01T00:00:00Z
P582
2012-06-01T00:00:00Z